Episode 13 - David Slack, CEO Impilo Therapeutics

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.

we have the pleasure of hosting David Slack, CEO of Impilo Therapeutics. With over 30 years of experience in the biopharmaceutical industry, David has a proven track record in creating value for companies and investors through strategic partnerships and innovative financing transactions.

David’s impressive career includes leadership roles at public and private biotech firms, as well as major pharmaceutical companies. He played a pivotal role in the merger of Cend Therapeutics with Caladrius Biosciences to form Lisata Therapeutics, and later co-founded Impilo Therapeutics to focus on nucleic acid-based medicine for treating solid tumor cancers.

In this episode, we'll explore David's journey from R&D to business development, the challenges and opportunities in the biotech industry, and the exciting future of Impilo Therapeutics.

Enjoy and stay tuned!